Patrick Loustau
Keine laufenden Positionen mehr
Profil
Patrick Loustau formerly worked at Bristol Myers Squibb Co., as Senior Vice President-Global Commercialization in 2014, Novo Nordisk A, as Senior VP-Global Marketing & Medical Affairs in 2010, and Zafgen, Inc., as President from 2014 to 2016.
Mr. Loustau received his graduate degree from Université de Paris XI Paris Sud.
Ehemalige bekannte Positionen von Patrick Loustau
| Unternehmen | Position | Ende |
|---|---|---|
| LARIMAR THERAPEUTICS, INC. | Präsident | 19.07.2016 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01.04.2014 |
| NOVO NORDISK A/S | Corporate Officer/Principal | 01.07.2010 |
Ausbildung von Patrick Loustau
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| NOVO NORDISK A/S | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Zafgen, Inc.
 Zafgen, Inc. BiotechnologyHealth Technology Zafgen, Inc. is a biopharmaceutical company, which engages in the development of novel therapies for patients affected by complex metabolic diseases. It focuses on the study of MetAP2 inhibitors in both common and rare metabolic disorders. The firm also advancing programs for type 2 diabetes, Prader-Willi syndrome, and liver diseases. The company was founded on November 22, 2005 and is headquartered in Boston, MA. | Health Technology |
| Université de Paris XI Paris Sud | Consumer Services |
